6q12 and 11p14 variants are associated with postnatal exhaled nitric oxide levels and respiratory symptoms

The identification of novel genetic determinants of infant eNO levels might implicate that postnatal eNO metabolism in healthy infants before first viral infections and sensitization is related to mechanisms other than those associated with asthma, atopy, or increased risk thereof later in life.